ATR and cancer: Several groups and pharmaceutical companies have focused on the identification of ATR inhibitors for cancer treatment, and four molecules targeting ATR are currently in clinical studies, namely, VX-970, VX-803, BAY1895344 and AZD6738 (Bradbury et al., 2020).